Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
FBT ETF · First Trust NYSE Arca Biotechnology Index Fund ETF
The FBT Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: NYSE Arca Biotechnology Index. The FBT ETF provides physical exposure, so by buying it you actually own parts of all the 30 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Today at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.-3.88%
Last price
$192.63
1M perf.
-5.58%
1M flows
+€9.2M
AuM
€1.93B
E/R
0.54%
Rating
ESG Consensus®
FBT
$192.63
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
FBT
$193.64
-7.34%
US Health Care
-2.59%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.58%  | -7.34% | +15.04%  | +29.35% | +20.07% | -7.27% | -5.96% | -5.96% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/12/2026
$193.64
1D NAV change
-2.86%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
30
Inception date
6/19/2006
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology IndexSM. The NYSE Arca Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
FBT
1M perf.
-5.59%
E/R
0.6%
FBT
1M perf.
-5.47%
E/R
0.72%
00678
1M perf.
+0.59%
E/R
1.01%
203780
1M perf.
+1.98%
E/R
0.3%
IHI
1M perf.
-4.11%
E/R
0.38%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -7.34% | +15.04% | +29.35% | +20.07% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
96.12%
Ireland
3.83%
Sectors
Health Care
89.80%
Unavailable
10.20%
Diversification
Total weight of top 15 holdings out of 30
Top 15 holdings
Data as of January 31, 2026
MODERNA INC
GILEAD SCIENCES
ALKERMES
BIONTECH SE ADR
KRYSTAL BIOTECH INC
US04016X1019
CORCEPT THERAPEUTICS
AMGEN-T
Create a free account to view top holdings
ILLUMINA
VERTEX PHARMACEUTICALS
US07725L1026
NEUROCRINE BIOSCIENCES
EXACT SCIENCES
HALOZYME THERAPEUTICS
NATERA
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about FBT ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
FBT’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
84.02% of holdings have positive scoring
16.03% of holdings have negative scoring
22.62%
47.33%
14.07%
9.98%
6.04%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
NYSE Arca Biotechnology Total Return Index - USD
Index ticker
BTKTR Index
Index dividend policy
GTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
First Trust
First Trust ID Card
Number of funds
401
Total AuM
€211.16B
Expense ratio range
0.15% - 13.69%
Average expense ratio
0.7991%
Top 5 funds by First Trust
| AuM | ||
|---|---|---|
RDVY | First Trust NASDAQ Rising Dividend Achievers ETF | €17.19B |
SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | €8.73B |
CIBR | First Trust NASDAQ Cybersecurity ETF | €8.53B |
BUFR | FT Vest Fund of Buffer ETF | €7.48B |
FVD | First Trust Value Line Dividend ETF - USD | €7.16B |
Frequently asked questions about FBT
What does First Trust NYSE Arca Biotechnology Index Fund ETF, FBT, invest in?
FBT is a Passive ETF. This ETF provides exposure to Equally Weighted US Biotechnology Equities.
Which benchmark or index does FBT replicate?
FBT tracks the NYSE Arca Biotechnology Total Return Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of FBT?
FBT carries a total expense ratio (TER) of 0.54%, indicating the annual cost for holding the fund.
When was FBT launched?
FBT was introduced to the market on June 19, 2006. It trades on United States
Who is the ETF issuer of FBT?
First Trust NYSE Arca Biotechnology Index Fund ETF, FBT, is provided by First Trust. Learn more about First Trust here.
What is the current assets under management (AUM) of FBT?
FBT oversees €1.93B in assets as of March 12, 2026.
How has FBT performed lately?
Based on data from March 12, 2026, FBT returned -5.58% over the past month, -7.34% over the last three months and -5.96% year-to-date.
What are the latest inflows or outflows for FBT?
As of March 12, 2026, FBT recorded net flows of +€8.9M over the last month and +€935M year-to-date.
Does FBT distribute dividends?
FBT follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of FBT?
As of January 31, 2026, FBT has significant geographic allocations in USA and Ireland.
In which sector or theme does FBT invest in?
As of January 31, 2026, FBT focuses largely on Health Care.
How many securities does FBT hold and how diversified is it?
As of January 31, 2026, FBT holds 30 positions in its portfolio, with 53.69% of assets concentrated in its top 15 holdings.
What are the main positions in FBT?
As of January 31, 2026, FBT top three holdings include MODERNA INC, GILEAD SCIENCES and ALKERMES.
What is the base currency of FBT?
The base currency of FBT is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
